Storm Therapeutics is a drug discovery company tackling oncology and other diseases through modulating RNA modifying enzymes. The company is developing a unique platform to address these enzyme classes, including RNA methyltransferases.
Atlantic Therapeutics has developed a CE marked and FDA approved, neuromuscular electrical stimulation device, Innovo™, that treats urinary and faecal incontinence in a non-invasive manner.
Novate Medical has developed a novel inferior vena cava filter that converts from a filter to a stent, providing protection to patients at risk of pulmonary embolism. Novate was sold to BTG in September 2018.
Biosensia merged with Kypha in 2018, a USA based in-vitro diagnostics company, to co-develop immune and inflammation assays on the Biosensia point-of-care RapiPlex platform.
Crescent Diagnostics has developed Osentia®, a commercially available diagnostic test to identify an individual’s risk of developing osteoporosis.
Alimentary Health has developed microbiome-based healthcare and nutritional products for inflammatory and other conditions.
Labcyte is developing the revolutionary Echo acoustic liquid handling technology for applications in research and drug development – Seroba’s investee company Deerac Fluidics sold to Labcyte Inc. in 2008. Labcyte was acquired by Beckman Coulter in 2019.